GENEVA, Feb. 15 -- IMMUNE BIOSOLUTIONS INC. (2-2650, rue Maximilien-ChagnonSherbrooke, Quebec J1E 0M8) filed a patent application (PCT/CA2025/051030) for "ANTI-LILRB2 BINDING MOLECULES AND USES THEREOF" on Aug 01, 2025. With publication no. WO/2026/030815, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GAUDREAU, Simon (325 rue ChampetreSherbrooke, Quebec J1E 4L9), GBRIC, Djorjde (1043 rue BeaudinSherbrooke, Quebec J1N 4B6), DUCLOS, Catherine (597 rue Marcel-GingrasSherbrooke, Quebec J1E 0L3), TESSIER, Laurence (250 rue d...